Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Robert Azelby Insider Profile

4 Followers

Robert Azelby, Director at Autolus Therapeutics, holds ― shares in Autolus Therapeutics (Ticker: AUTL), holds 4.08K shares in Cardinal Health (Ticker: CAH), holds ― shares in Clovis Oncology (Ticker: CLVSQ).

Robert Azelby's Trading History

TNGXTango Therapeutics		Jun 23, 2026DirectorUninformative Buy―$130.41K
ADCTADC Therapeutics		Jun 03, 2026DirectorUninformative Buy―$172.59K
CAHCardinal Health		Nov 06, 2025DirectorUninformative Buy―$1.02M
IMMUImmunomedics		Jun 22, 2020―Uninformative Buy―$326.66K
JUNOJuno Therapeutics		Mar 07, 2018―Uninformative Sell―$0.00
CLYMClimb Bio		―President & CEO, Director――
TERNTerns Pharmaceuticals		――――
KDNYChinook Therapeutics		――――
ALDRAlder Biopharmaceuticals		――――
CASCCascadian Therapeutics		――――
CLVSQClovis Oncology		――――
AUTLAutolus Therapeutics		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Robert Azelby insider profile FAQ

What stocks does Robert Azelby hold?
Robert Azelby holds: AUTL, CAH, CLVSQ, IMMU, CASC, ALDR, JUNO, KDNY, ADCT, TNGX, TERN, CLYM stocks.
What is Robert Azelby's role in Autolus Therapeutics?
Robert Azelby's role in Autolus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.